Biohaven Pharmaceutical H...

AI Score

XX

Unlock

22.62
-1.42 (-5.91%)
At close: Apr 01, 2025, 3:59 PM
21.52
-4.86%
Pre-market: Apr 02, 2025, 04:44 AM EDT

Biohaven Pharmaceutical Ltd. Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -4.03 -7.47 -1.09 -1.22 -2.2 -0.67 n/a n/a
PEG Ratio -0.06 0.14 -0.01 -0.02 0.03 n/a n/a n/a
PS Ratio n/a n/a n/a 0.57 n/a n/a n/a n/a
PB Ratio 8.05 7.12 1.15 7.54 15.58 -47.68 n/a n/a
P/FCF Ratio -5.81 -9.1 -1.83 -1.78 -3.32 -0.93 n/a n/a
P/OCF Ratio -5.85 -9.19 -2.09 -1.79 -3.44 -0.94 n/a n/a
OCF/S Ratio n/a n/a n/a -0.32 n/a n/a n/a n/a
Debt / Equity Ratio 0.08 0.07 0.06 18.07 15.94 n/a 0.78 n/a
Quick Ratio 3.49 7.99 5.90 2.10 1.68 4.96 13.94 14.49
Current Ratio 3.49 7.98 6.52 2.26 3.00 4.96 13.94 14.49
Asset Turnover n/a n/a n/a 3.26 n/a n/a n/a n/a
Interest Coverage n/a n/a n/a n/a n/a 37.69 n/a n/a
Return on Equity -2 -0.95 -1.06 -6.16 -7.07 71.23 n/a n/a
Return on Assets -1.38 -0.8 -0.86 -1.5 -1.06 -1.54 n/a n/a
Return on Invested Capital -1.92 -0.94 -0.99 -2.2 -1.39 -1.72 n/a n/a
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a 0.80 n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a -0.46 n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a -0.46 n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a -0.47 n/a n/a n/a n/a
FCF Margin n/a n/a n/a -31.74 n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a -0.47 n/a n/a n/a n/a